Estimating the lost benefits of antiretroviral drug use in South Africa.

@article{Chigwedere2008EstimatingTL,
  title={Estimating the lost benefits of antiretroviral drug use in South Africa.},
  author={P. Chigwedere and G. Seage and S. Gruskin and T. Lee and M. Essex},
  journal={Journal of acquired immune deficiency syndromes},
  year={2008},
  volume={49 4},
  pages={
          410-5
        }
}
South Africa is one of the countries most severely affected by HIV/AIDS. At the peak of the epidemic, the government, going against consensus scientific opinion, argued that HIV was not the cause of AIDS and that antiretroviral (ARV) drugs were not useful for patients and declined to accept freely donated nevirapine and grants from the Global Fund. Using modeling, we compared the number of persons who received ARVs for treatment and prevention of mother-to-child HIV transmission between 2000… Expand
271 Citations
The adequacy of policy responses to the treatment needs of South Africans living with HIV (1999-2008): a case study
  • J. Gow
  • Medicine
  • Journal of the International AIDS Society
  • 2009
  • 10
  • PDF
Prevention of mother-to-child transmission in South Africa: an ever-changing landscape
  • 22
  • Highly Influenced
Provision of antiretroviral therapy in South Africa: the nuts and bolts.
  • 70
  • PDF
The Effect of Access to AIDS Treatment on Employment Outcomes in South Africa
  • 17
  • PDF
Population-level associations between antiretroviral therapy scale-up and all-cause mortality in South Africa
  • 9
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 43 REFERENCES
Cost-Effectiveness of Highly Active Antiretroviral Therapy in South Africa
  • 145
  • PDF
Management of HIV-infected children.
  • 21
The cost-effectiveness of Antiretroviral Treatment in Khayelitsha, South Africa – a primary data analysis
  • 142
  • PDF
The survival benefits of AIDS treatment in the United States.
  • 520
  • Highly Influential
  • PDF
Integrating HIV Prevention and Treatment: From Slogans to Impact
  • 178
  • PDF
Potential Impact of Antiretroviral Therapy on HIV-1 Transmission and AIDS Mortality in Resource-Limited Settings
  • 85
Cost-effectiveness of HIV treatment in resource-poor settings--the case of Côte d'Ivoire.
  • 260
  • PDF
Model for simulation of HIV/AIDS and cost-effectiveness of preventing non-tuberculous mycobacterial (MAC)-disease
  • 9
Paying to waste lives: the affordability of reducing mother-to-child transmission of HIV in South Africa.
  • 43
...
1
2
3
4
5
...